Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Darzalex
Pharma
Sanofi's subQ version of Sarclisa measures up to its IV version
A phase 3 trial of Sanofi's subcutaneous version of Sarclisa has met its primary co-endpoints, showing non-inferiority to intravenous Sarclisa.
Kevin Dunleavy
Jan 9, 2025 11:14am
ICER calls out drugmakers over 'unsupported' price hikes
Dec 12, 2024 2:24pm
ASH: GSK details Blenrep's survival win against J&J's Darzalex
Dec 9, 2024 1:30pm
GSK's ADC Blenrep delivers survival win against J&J's Darzalex
Nov 14, 2024 9:24am
J&J angles Darzalex for first move into early-stage myeloma
Nov 8, 2024 9:53am
J&J leans on oncology growth drivers as Stelara sales slow
Oct 15, 2024 11:45am